Articles

Creative Medical Technology Holdings, Inc. Designation Granted By FDA For This Medical Tech Company | by Stock Region

0
Please log in or register to do it.


FDA Grants Orphan Drug Designation to Creative Medical Technology’s CELZ-101: A Major Breakthrough in Transplantation Therapy

As an investor it’s important to stay updated with major news. Get real-time stock market alerts, news, and research by creating an account here.

In a significant development that could potentially revolutionize transplantation therapy, Creative Medical Technology Holdings, Inc. has received the FDA’s Orphan Drug Designation for its innovative drug, CELZ-101. This breakthrough holds the promise of improving the lives of many patients who rely on transplantation therapy.

Orphan Drug Designation Granted By FDA For This Medical Tech Company
Photo by Marcel Scholte on Unsplash

Creative Medical Technology Holdings, Inc., publicly traded under the ticker symbol $CELZ, is a clinical-stage biotechnology company specializing in regenerative medicine and stem cell technology. With a focus on developing novel treatments for unmet medical needs, the company is at the forefront of medical innovation.

The FDA’s Orphan Drug Designation for CELZ-101 marks a significant milestone for the company. This designation not only acknowledges the potential of this innovative therapy but also provides incentives that could accelerate its development and approval.

CELZ-101, also known as ImmCelz™, is a cutting-edge therapy that aims to prevent allograft rejection, a common issue in transplantation therapy. By leveraging the body’s own immune cells, this therapy could offer a new approach to improve graft survival and patient outcomes.

The use of CELZ-101 in transplantation therapy, particularly for patients requiring islet transplantation, could significantly improve treatment options. As a result, this development has been met with much enthusiasm from both the medical community and investors, with shares of Creative Medical Technology rallying premarket following the announcement.



Source link

“Mastering Success: Unveiling the 7 Habits of Highly Effective People” | by CS Media | Mar, 2024
Why Do Most Relationships Fail?. The Myth of the Magical Other | by J-Loaded | Mar, 2024
Ads by AdZippy

Your email address will not be published. Required fields are marked *